Unichem Laboratories Overview

  • Year Founded
  • 1944

Year Founded

  • Status
  • Public

  • Employees
  • 2,153

Employees

  • Stock Symbol
  • 506690

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $9.94
  • (As of Friday Closing)

Unichem Laboratories General Information

Description

Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a global market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Prabhat Estate
  • Off S.V.Road, Jogeshwari (West)
  • Mumbai, Maharashtra 400102
  • India
+91 022
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • Prabhat Estate
  • Off S.V.Road, Jogeshwari (West)
  • Mumbai, Maharashtra 400102
  • India
+91 022

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Unichem Laboratories Stock Performance

As of 29-Nov-2024, Unichem Laboratories’s stock price is $9.94. Its current market cap is $700M with 70.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.94 $9.82 $4.82 - $11.25 $700M 70.4M 9.3K

Unichem Laboratories Financials Summary

As of 30-Sep-2024, Unichem Laboratories has a trailing 12-month revenue of $207M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 565,263 439,259 244,169 249,612
Revenue 207,159 200,205 162,199 167,497
EBITDA 16,285 8,825 (5,876) 14,997
Net Income (668) (8,513) (25,185) 4,437
Total Assets 395,495 380,047 388,917 437,670
Total Debt 35,847 29,680 38,251 46,045
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Unichem Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Unichem Laboratories‘s full profile, request access.

Request a free trial

Unichem Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingr
Pharmaceuticals
Mumbai, India
2,153 As of 2024

Panchkula, India

Mumbai, India
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Unichem Laboratories Competitors (2)

One of Unichem Laboratories’s 2 competitors is Mint Lifesciences Pvt, a Corporation company based in Panchkula, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mint Lifesciences Pvt Corporation Panchkula, India
Mehta API Private Corporation Mumbai, India
You’re viewing 2 of 2 competitors. Get the full list »

Unichem Laboratories Patents

Unichem Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022410688-A1 Recombinant protein for treating sars-cov2 disease Pending 16-Dec-2021
CA-3239504-A1 Recombinant protein for sars-cov2 disease Pending 16-Dec-2021
EP-4447992-A1 Recombinant protein for treating sars-cov2 disease Pending 16-Dec-2021
CA-3230395-A1 Lectin-drug conjugates Pending 01-Oct-2021
CA-3229988-A1 Recombinant glycan binding proteins and its use Pending 01-Oct-2021 C07K14/37
To view Unichem Laboratories’s complete patent history, request access »

Unichem Laboratories Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Unichem Laboratories Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Unichem Laboratories‘s full profile, request access.

Request a free trial

Unichem Laboratories Investments & Acquisitions (4)

Unichem Laboratories’s most recent deal was a Merger/Acquisition with Bayshore Pharmaceuticals (US Generics Formulations Marketing and Distribution Business) for . The deal was made on 01-Oct-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bayshore Pharmaceuticals (US Generics Formulations Marketing and Distribution Business) 01-Oct-2024 Merger/Acquisition Drug Discovery
Optimus Pharma 05-Nov-2018 Corporate Pharmaceuticals
Niche Generics 15-Dec-2006 Secondary Transaction - Private Pharmaceuticals
Niche Generics 01-Apr-2002 Merger/Acquisition Pharmaceuticals
To view Unichem Laboratories’s complete investments and acquisitions history, request access »

Unichem Laboratories Subsidiaries (1)

Company Name Industry Location Founded
Niche Generics Pharmaceuticals Arlesey, United Kingdom
To view Unichem Laboratories’s complete subsidiaries history, request access »

Unichem Laboratories ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Unichem Laboratories’s complete esg history, request access »

Unichem Laboratories FAQs

  • When was Unichem Laboratories founded?

    Unichem Laboratories was founded in 1944.

  • Where is Unichem Laboratories headquartered?

    Unichem Laboratories is headquartered in Mumbai, India.

  • What is the size of Unichem Laboratories?

    Unichem Laboratories has 2,153 total employees.

  • What industry is Unichem Laboratories in?

    Unichem Laboratories’s primary industry is Pharmaceuticals.

  • Is Unichem Laboratories a private or public company?

    Unichem Laboratories is a Public company.

  • What is Unichem Laboratories’s stock symbol?

    The ticker symbol for Unichem Laboratories is 506690.

  • What is the current stock price of Unichem Laboratories?

    As of 29-Nov-2024 the stock price of Unichem Laboratories is $9.94.

  • What is the current market cap of Unichem Laboratories?

    The current market capitalization of Unichem Laboratories is $700M.

  • What is Unichem Laboratories’s current revenue?

    The trailing twelve month revenue for Unichem Laboratories is $207M.

  • Who are Unichem Laboratories’s competitors?

    Mint Lifesciences Pvt and Mehta API Private are competitors of Unichem Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »